Wieke M. Van Oostveen
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Disease activity and anti-topoisomerase I antibody positivity are associated with elevated serum B cell activating factor levels and a B cell subset-wide reduction of BAFF-receptor expression in SSc.
Journal: Rheumatology (Oxford, England)
Published: February 23, 2026
Disease activity and anti-topoisomerase I antibody positivity are associated with elevated serum B cell-activating factor levels and a B cell subset-wide reduction of BAFF receptor expression in systemic sclerosis.
Journal: Rheumatology (Oxford, England)
Published: February 23, 2026
Autoantibodies directed against the angiotensin II type 1 receptor and the endothelin-1 type A receptor in patients with systemic sclerosis.
Journal: RMD open
Published: April 11, 2025
Absence of Functional Autoantibodies Targeting Angiotensin II Receptor Type 1 and Endothelin-1 Type A Receptor in Circulation and Purified IgG From Patients With Systemic Sclerosis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: September 12, 2024
Pathogenic role of anti-nuclear autoantibodies in systemic sclerosis: Insights from other rheumatic diseases.
Journal: Immunological reviews
Published: September 09, 2024
Label-free detection of prostaglandin transporter (SLCO2A1) function and inhibition: insights by wound healing and TRACT assays.
Journal: Frontiers in pharmacology
Published: January 17, 2024
Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium.
Journal: Autoimmunity reviews
Published: February 09, 2023
Imaging Techniques in Alzheimer's Disease: A Review of Applications in Early Diagnosis and Longitudinal Monitoring.
Journal: International journal of molecular sciences
Published: December 15, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026